Drugs / Antioxidant Supplements for Thyroid Eye Disease
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02422368 | Sep 2022 → Jun 2024 | endocrine exophthalmos | Iran University of Medical Sciences | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antioxidant Supplements for Thyroid Eye Disease | “ASTED (Antioxidant Supplements for Thyroid Eye Disease) includes : B-Carotene (6 mg)+ Vit.C (200 mg) + Vit.E (200 mg) + Nicotinamide(20mg) + Selenium(200mic.) + Zinc oxide (8...” NCT02422368 ↗ |
| Known as | ASTED | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02422368 ↗ |